Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alexander Decruyenaere, Koen Kortbeek, Sigurd Delanghe, Sylvie Rottey, Hannelore Denys & Lore Lapeire. (2023) Incidence, evolution and risk factors of hypophosphatemia in patients with solid tumors receiving ferric carboxymaltose: a retrospective cohort study. Acta Clinica Belgica 78:4, pages 298-307.
Read now
Read now
Articles from other publishers (5)
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, O. A. Gromova & I. Yu. Torshin. (2022) Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15:1, pages 73-86.
Crossref
Crossref
Jyoti Milind KharcheDr.Dr. & Nilofer Bano Isa PatelDr.Dr.. (2021) TO STUDY CLINICAL SIGNIFICANCE OF RETICULOCYTE HAEMOGLOBIN CONTENT IN IRON DEFICIENCY ANEMIA. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 39-42.
Crossref
Crossref
N. A. Romanenko, A. E. Alborov, S. S. Bessmeltsev, E. R. Shilova, S. V. Voloshin & A. V. Chechetkin. (2020) Pathogenetic and substitution correction of anemia in patients with malignant neoplasms. Oncohematology 15:3, pages 95-106.
Crossref
Crossref
Rhona CF Sinclair, Kate E Duffield & Jane H de Pennington. (2020) Improving preoperative haemoglobin using a quality improvement approach to treat iron deficiency anaemia. BMJ Open Quality 9:1, pages e000776.
Crossref
Crossref
. (2019) Ferric carboxymaltose. Reactions Weekly 1737:1, pages 135-135.
Crossref
Crossref